Global Brain has invested in Rhelixa, Inc., a leading company in epigenome analysis

Global Brain has invested in Rhelixa, Inc. (Rhelixa), a leading company in epigenome analysis, through its KIRIN HEALTH INNOVATION FUND.

Rhelixa is a startup from the University of Tokyo that specializes in advanced analysis of genomic data, including the epigenome*¹. With the mission of “Decoding Life, Creating Future,” Rhelixa positions itself as a leading company in epigenome analysis by leveraging its proprietary technology and expertise to analyze omics data, thereby contributing to the efficiency and accuracy of its clients’ research and development.
*¹ The epigenome refers to a collection of information that activates or inactivates the function of the genome (DNA) through modifications.

In recent years, the traditional view that “aging is an inevitable phenomenon” has shifted to the recognition that “aging is a disease that can be prevented and treated,” leading to accelerated global efforts to fundamentally prevent and treat aging. With extensive experience in analysis within Japan, Rhelixa has earned considerable trust and is now working on the social implementation of its unique biological age*² (aging) measurement service, the “Epiclock™ Test.” Starting this fall, the company plans to launch a service that provides cellular aging evaluation results and intervention plans for longevity through select medical institutions. Through this Epiclock™ business, Rhelixa aims to contribute to the creation and growth of the longevity market in Japan and Asia, while also supporting research activities that evaluate the anti-aging effects of lifestyle improvements and specific interventions, and developing new anti-aging solutions in collaboration with companies and research institutions.
*² Biological age refers to the age based on the state of the body’s cells and tissues. Unlike chronological age, which reflects the number of years since birth, biological age reflects physical functions and the degree of aging.

Global Brain has decided to invest in Rhelixa, based on its high regard for Rhelixa’s business and talented management team with the ability to bring its plans to fruition. Global Brain will contribute to the growth of Rhelixa’s business in collaboration with Kirin Holdings.